1. Home
  2. SPRY vs NX Comparison

SPRY vs NX Comparison

Compare SPRY & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • NX
  • Stock Information
  • Founded
  • SPRY 2015
  • NX 1927
  • Country
  • SPRY United States
  • NX United States
  • Employees
  • SPRY N/A
  • NX N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • NX Metal Fabrications
  • Sector
  • SPRY Health Care
  • NX Industrials
  • Exchange
  • SPRY Nasdaq
  • NX Nasdaq
  • Market Cap
  • SPRY 1.6B
  • NX 852.8M
  • IPO Year
  • SPRY N/A
  • NX N/A
  • Fundamental
  • Price
  • SPRY $17.61
  • NX $18.62
  • Analyst Decision
  • SPRY Strong Buy
  • NX Strong Buy
  • Analyst Count
  • SPRY 4
  • NX 1
  • Target Price
  • SPRY $28.75
  • NX $38.00
  • AVG Volume (30 Days)
  • SPRY 1.6M
  • NX 416.7K
  • Earning Date
  • SPRY 08-05-2025
  • NX 09-04-2025
  • Dividend Yield
  • SPRY N/A
  • NX 1.70%
  • EPS Growth
  • SPRY N/A
  • NX N/A
  • EPS
  • SPRY N/A
  • NX 0.39
  • Revenue
  • SPRY $97,122,000.00
  • NX $1,625,028,000.00
  • Revenue This Year
  • SPRY N/A
  • NX $49.00
  • Revenue Next Year
  • SPRY $170.64
  • NX $2.99
  • P/E Ratio
  • SPRY N/A
  • NX $47.95
  • Revenue Growth
  • SPRY 971120.00
  • NX 47.66
  • 52 Week Low
  • SPRY $8.91
  • NX $15.30
  • 52 Week High
  • SPRY $18.90
  • NX $34.97
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 60.67
  • NX 52.51
  • Support Level
  • SPRY $16.40
  • NX $19.41
  • Resistance Level
  • SPRY $18.22
  • NX $21.59
  • Average True Range (ATR)
  • SPRY 0.97
  • NX 0.80
  • MACD
  • SPRY 0.01
  • NX -0.04
  • Stochastic Oscillator
  • SPRY 63.33
  • NX 41.04

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: